Addressing variability in newborn screening can prevent missed diagnoses and delays in early care intervention.
Site Search
Showing 1 - 10 of 26 results
News
|
Sept. 29, 2022
|
3 min read
CEO pledge is part of the Foundation’s ongoing commitment to strengthen the organization and better serve all people with CF
News
|
Sept. 1, 2022
|
3 min read
Orkambi® is now approved for use in children with cystic fibrosis ages 1-2 years who have two F508del mutations. This is the only modulator available to very young children with these mutations.
News
|
Sept. 2, 2022
|
3 min read
Dismal Swamp Canal Trail
Huntington Park
Greer City Park
Kakaako Regional Park
Washington Lake Park
Las Olas Oceanside Park
Westside Albert Ray Massey Park